Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Guru Fundamental Report for HOOD
Market Updates

Guru Fundamental Report for HOOD

Below is Validea's guru fundamental report for ROBINHOOD MARKETS INC (HOOD). Of the 22 guru strategies we follow, HOOD rates highest using our Quantitative Momentum Investor model based on the publish...

  • June 01, 2025 06:03 AM PDT
  • EODHD
A Glucose Monitor for Someone Without Diabetes: Optimal or Overkill?
Market Updates

A Glucose Monitor for Someone Without Diabetes: Optimal or Overkill?

Our columnist tried Dexcom’s Stelo wearable to see if the data could help her live—and eat—healthier. Continue Reading View Comments

  • June 01, 2025 06:00 AM PDT
  • EODHD
What Wall Street might be missing on Nvidia
Market Updates

What Wall Street might be missing on Nvidia

This is The Takeaway from today's Morning Brief, which you can sign up to receive in your inbox every morning along with: The chart of the day What we're watching What we're reading Economic data rele...

  • June 01, 2025 05:30 AM PDT
  • EODHD
Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
Market Updates

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease...

  • June 01, 2025 05:03 AM PDT
  • EODHD
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Market Updates

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease...

  • June 01, 2025 05:03 AM PDT
  • EODHD
Kelly Buick Gmc Receives 25 Year Dealer Award For Gmc
Market Updates

Kelly Buick Gmc Receives 25 Year Dealer Award For Gmc

LEHIGH VALLEY, Pa., June 1, 2025 (SEND2PRESS NEWSWIRE) -- The Kelly Auto Group is proud to announce that they recently received the 25-Year Dealer Award for GMC for their Buick/GMC dealership in Emmau...

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
Market Updates

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay...

  • June 01, 2025 04:00 AM PDT
  • EODHD
NIO May Vehicle Deliveries Up 13.1%
Market Updates

NIO May Vehicle Deliveries Up 13.1%

(RTTNews) - NIO Inc. (NIO), a Chinese multinational automobile manufacturer, Sunday reported that it delivered 23,231 vehicles in May 2025, up 13.1 percent year-over-year. The deliveries consisted of...

  • June 01, 2025 03:29 AM PDT
  • EODHD
JPMorgan Chief Strategist on Tariffs, Investing Abroad and More
Market Updates

JPMorgan Chief Strategist on Tariffs, Investing Abroad and More

David Kelly, Chief Global Strategist for J.P. Morgan Asset Management, joins WSJ’s Take On the Week podcast to explain the importance of global investment diversification. View Comments

  • June 01, 2025 03:00 AM PDT
  • EODHD
NIO delivers 23,231 vehicles in May
Market Updates

NIO delivers 23,231 vehicles in May

Andy Feng * NIO (NYSE:NIO [https://seekingalpha.com/symbol/NIO]) has delivered 23,231 vehicles in May 2025, representing an increase of 13.1% year-over-year, while down sequentially for 3rd month. * T...

  • June 01, 2025 02:57 AM PDT
  • EODHD